http://rdf.ncbi.nlm.nih.gov/pubchem/patent/RU-2294745-C2
Outgoing Links
Predicate | Object |
---|---|
assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_10efc646a4dd605c2f09c493718f5b81 |
classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-573 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P27-02 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-167 |
filingDate | 2005-06-01-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
grantDate | 2007-03-10-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_674e8d2fda7bc8272bfebcd247b11fd1 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_80ac5e09771f87f556ace833cca19c6b http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_eab2a7e926c244527fd1424ca5e999b3 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_14797318bec75aed51afb1326050563c |
publicationDate | 2007-03-10-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber | RU-2294745-C2 |
titleOfInvention | Method for treating malignant exophthalmos cases accompanied by thyrotoxicosis |
abstract | FIELD: medicine. n SUBSTANCE: method involves introducing injection needle through conjunctiva and conducting it in turn between the conjunctiva and sclera along each of four direct muscles of eye: superior direct muscle, inferior direct muscle, interior direct muscle and exterior direct muscle. Hydrocortisone suspension combined with lidocaine hydrochloride is injected into their bellies zone at a dose of 0.3 ml per each muscle. The total treatment course is 1-2 procedures long with 7 days long pause. n EFFECT: enhanced effectiveness of treatment; prolonged anti-inflammatory, anti-edematous and sclerosing drug action. n 2 dwg |
isCitedBy | http://rdf.ncbi.nlm.nih.gov/pubchem/patent/RU-2769980-C1 |
priorityDate | 2005-06-01-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 25.